Actinium Pharmaceuticals, Inc. (ATNM)

Actinium Pharmaceuticals Statistics

Total Valuation

ATNM has a market cap or net worth of $49.29 million. The enterprise value is -$9.35 million.

Market Cap	49.29M
Enterprise Value	-9.35M

Important Dates

The last earnings date was Friday, August 8, 2025, after market close.

Earnings Date	Aug 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ATNM has 31.20 million shares outstanding. The number of shares has increased by 10.84% in one year.

Current Share Class	31.20M
Shares Outstanding	31.20M
Shares Change (YoY)	+10.84%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.08%
Owned by Institutions (%)	20.70%
Float	30.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.59
P/TBV Ratio	2.59
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.34, with a Debt / Equity ratio of 0.07.

Current Ratio	7.34
Quick Ratio	7.21
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -130.59% and return on invested capital (ROIC) is -83.82%.

Return on Equity (ROE)	-130.59%
Return on Assets (ROA)	-36.18%
Return on Invested Capital (ROIC)	-83.82%
Return on Capital Employed (ROCE)	-80.89%
Revenue Per Employee	n/a
Profits Per Employee	-$1.11M
Employee Count	37
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.22% in the last 52 weeks. The beta is -0.30, so ATNM's price volatility has been lower than the market average.

Beta (5Y)	-0.30
52-Week Price Change	-12.22%
50-Day Moving Average	1.62
200-Day Moving Average	1.43
Relative Strength Index (RSI)	41.82
Average Volume (20 Days)	164,332

Short Selling Information

The latest short interest is 1.01 million, so 3.22% of the outstanding shares have been sold short.

Short Interest	1.01M
Short Previous Month	1.03M
Short % of Shares Out	3.22%
Short % of Float	3.26%
Short Ratio (days to cover)	4.61

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-44.25M
Pretax Income	-42.62M
Net Income	-41.04M
EBITDA	-44.04M
EBIT	-44.25M
Earnings Per Share (EPS)	-$1.32

Balance Sheet

The company has $59.93 million in cash and $1.29 million in debt, giving a net cash position of $58.64 million or $1.88 per share.

Cash & Cash Equivalents	59.93M
Total Debt	1.29M
Net Cash	58.64M
Net Cash Per Share	$1.88
Equity (Book Value)	19.01M
Book Value Per Share	0.61
Working Capital	52.72M

Cash Flow

Operating Cash Flow	-30.69M
Capital Expenditures	n/a
Free Cash Flow	-30.69M
FCF Per Share	-$0.98

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ATNM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.84%
Shareholder Yield	-10.84%
Earnings Yield	-83.26%
FCF Yield	-62.27%

Analyst Forecast

The average price target for ATNM is $4.50, which is 184.81% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	184.81%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-29.32%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on August 11, 2020. It was a reverse split with a ratio of 1:30.

Last Split Date	Aug 11, 2020
Split Type	Reverse
Split Ratio	1:30

Scores

Altman Z-Score	n/a
Piotroski F-Score	1